On 4th February, this World Cancer Day, the National Comprehensive Cancer Network (NCCN) unites with associations all across the world to attract attention to inequities in cancer care and work to handle them. “Close the care gap” is the new campaign conducted by the Union for International Cancer Control (UICC) that will promote equity in health care for different races/ethnicities, socioeconomic groups, sexual orientations, gender identities, regions, and more.
According to Robert W. Carlson, MD, Chief Executive Officer, NCCN:
The identity and address of a person should not determine the healthcare someone receives. Still, there are disparities in the health care received by the U.S. and other countries. There are differences in health care for different communities of people within the U.S. So this World Cancer Day, NCCN will discover and manage the important barriers that stop too many people from acquiring high-quality cancer care.
Previously on World Cancer Day global strategy for eliminating cervical cancer was announced by World Health Organization. According to UICC, the survival rate of women with cervical cancer is more for white women than for black women in the U.S. The mortality rate for cervical cancer is more than 90% in low and middle-income households. Only 20% of the children from low-income households survive from cancer while the survival rate in high-income households is 80%.
There are significant differences between the cancer care received by different groups of people even in high-income countries like the U.S. So on World Cancer Day, NCCN and UICC tries to uncover and close the care gap received by different communities.
Dr. Cary Adams, CEO of UICC, says:
Healthcare organizations should come together and break down barriers. Over the last 10 years, UICC has achieved a lot in cancer care and control around the world but not handling inequities in society is delaying their progress. Closing the care gap is about fairness, dignity, and fundamental rights to let everyone have better health and live a longer life.
The NCCN Guidelines in Oncology is a resource that standardizes the best available quality in cancer care and stops improper or insufficient management. Many separate studies reveal that standardized care enhances results, but is not always used equally for all patient groups.
READ MORE: Immorna Biotherapeutics, Inc. Expands R&D Footprint in RTP, NC